Cynata Therapeutics is a stem cell and regenerative medicine company focused on the development of therapies based on Cymerus, a proprietary therapeutic stem cell platform technology. It specializes in stem cells known as mesenchymoangioblasts (MCAs). MCAs are a precursor of mesenchymal stem cells (MSCs), which are at the forefront of treatments for osteoarthritis, Crohn’s, and heart disease.